Braeburn Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Buy
5,487
+441
+9% +$51.6K 0.3% 56
2026
Q1
$607K Buy
5,046
+87
+2% +$10K 0.35% 50
2025
Q4
$522K Buy
+4,959
New +$466K 0.27% 54

Other funds holding MRK

Braeburn Wealth Management's MRK Position: Q2 2026 in Review

Braeburn Wealth Management increased its Merck (MRK) stake by 8.7% in Q2 2026, buying an estimated $51.6K and bringing the position to 5,487 shares worth $705K. The position accounts for 0.3% of the portfolio, ranked #56.

Braeburn Wealth Management first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Braeburn Wealth Management held 5,487 shares of Merck worth $705K as of Q2 2026.
  • Braeburn Wealth Management bought 441 Merck shares in Q2 2026, an estimated $51.6K.
  • Merck made up 0.3% of Braeburn Wealth Management's portfolio in Q2 2026, its #56 holding.
  • Braeburn Wealth Management first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Braeburn Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.